Preservation and redirection of HPV16E7-specific T cell receptors for immunotherapy of cervical cancer

Clinical Immunology

Volumn 114, Issue 2, 2005, Pages 119-129

  Scholten, Kirsten B J ^a   Schreurs, Marco W J ^a   Ruizendaal, Janneke J ^a   Kueter, Esther W M ^a   Kramer, Duco ^a   Veenbergen, Sharon ^a   Meijer, Chris J L M ^a   Hooijberg, Erik ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cervical carcinoma; Immunotherapy; Retroviral transduction; TCR transfer

Indexed keywords

EPITOPE; GAMMA INTERFERON; HLA A2 ANTIGEN; T LYMPHOCYTE RECEPTOR;

ADOPTIVE TRANSFER; ANTIGEN SPECIFICITY; ARTICLE; CANCER IMMUNOTHERAPY; CELL CLONE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DRUG ACTIVITY; FEMALE; GENE EXPRESSION; GENE ISOLATION; GENE TRANSFER; GENETIC ENGINEERING; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; LEUKEMIA CELL LINE; NONHUMAN; PRIORITY JOURNAL; TRANSGENICS; UTERINE CERVIX CANCER; VIRUS INFECTION;

AMINO ACID SEQUENCE; BASE SEQUENCE; CLONING, MOLECULAR; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOTHERAPY, ADOPTIVE; JURKAT CELLS; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RECEPTORS, ANTIGEN, T-CELL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; T-LYMPHOCYTES, CYTOTOXIC; TRANSDUCTION, GENETIC; UTERINE CERVICAL NEOPLASMS;

EID: 11444268812     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clim.2004.11.005     Document Type: Article

References (40)

1. H. zur Hausen Condylomata acuminata and human genital cancer Cancer Res. 36 1976 794
2. J.M. Walboomers, M.V. Jacobs, M.M. Manos, F.X. Bosch, J.A. Kummer, K.V. Shah, P.J. Snijders, J. Peto, C.J. Meijer, and N. Munoz Human papillomavirus is a necessary cause of invasive cervical cancer worldwide J. Pathol. 189 1999 12 19
3. L.A. Koutsky, K.A. Ault, C.M. Wheeler, D.R. Brown, E. Barr, F.B. Alvarez, L.M. Chiacchierini, and K.U. Jansen A controlled trial of a human papillomavirus type 16 vaccine N. Engl. J. Med. 347 2002 1645 1651
4. X.W. Sun, L. Kuhn, T.V. Ellerbrock, M.A. Chiasson, T.J. Bush, and T.C. Wright Jr. Human papillomavirus infection in women infected with the human immunodeficiency virus N. Engl. J. Med. 337 1997 1343 1349
5. I.H. Frazer Prevention of cervical cancer through papillomavirus vaccination Nat. Rev., Immunol. 4 2004 46 54
6. M. Nimako, A.N. Fiander, G.W. Wilkinson, L.K. Borysiewicz, and S. Man Human papillomavirus-specific cytotoxic T lymphocytes in patients with cervical intraepithelial neoplasia grade III Cancer Res. 57 1997 4855 4861
7. E.M. Evans, S. Man, A.S. Evans, and L.K. Borysiewicz Infiltration of cervical cancer tissue with human papillomavirus-specific cytotoxic T-lymphocytes Cancer Res. 57 1997 2943 2950
8. M.E. Dudley, J.R. Wunderlich, P.F. Robbins, J.C. Yang, P. Hwu, D.J. Schwartzentruber, S.L. Topalian, R. Sherry, N.P. Restifo, A.M. Hubicki, M.R. Robinson, M. Raffeld, P. Duray, C.A. Seipp, L. Rogers-Freezer, K.E. Morton, S.A. Mavroukakis, D.E. White, and S.A. Rosenberg Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes Science 298 2002 850 854
9. + T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells Proc. Natl. Acad. Sci. U. S. A. 99 2002 16168 16173
10. M.W.J. Schreurs, K.B.J. Scholten, E.W.M. Kueter, J.J. Ruizendaal, C.J.L.M. Meijer, and E. Hooijberg In vitro generation and life span extension of human papillomavirus type 16-specific, healthy donor-derived CTL clones J. Immunol. 171 2003 2912 2921
11. S.J. Youde, P.R. Dunbar, E.M. Evans, A.N. Fiander, L.K. Borysiewicz, V. Cerundolo, and S. Man Use of fluorogenic histocompatibility leukocyte antigen-A*0201/HPV 16 E7 peptide complexes to isolate rare human cytotoxic T-lymphocyte-recognizing endogenous human papillomavirus antigens Cancer Res. 60 2000 365 371
12. M.H. Heemskerk, M. Hoogeboom, R.A. de Paus, M.G. Kester, M.A. Van Der Hoorn, E. Goulmy, R. Willemze, and J.H. Falkenburg Redirection of anti-leukemic reactivity of peripheral T lymphocytes using gene transfer of minor histocompatibility antigen HA-2-specific T-cell receptor complexes expressing a conserved alpha joining region Blood 2003
13. T.M. Clay, M.C. Custer, J. Sachs, P. Hwu, S.A. Rosenberg, and M.I. Nishimura Efficient transfer of a tumor antigen-reactive TCR to human peripheral blood lymphocytes confers anti-tumor reactivity J. Immunol. 163 1999 507 513
14. R.A. Morgan, M.E. Dudley, Y.Y. Yu, Z. Zheng, P.F. Robbins, M.R. Theoret, J.R. Wunderlich, M.S. Hughes, N.P. Restifo, and S.A. Rosenberg High efficiency TCR gene transfer into primary human lymphocytes affords avid recognition of melanoma tumor antigen glycoprotein 100 and does not alter the recognition of autologous melanoma antigens J. Immunol. 171 2003 3287 3295
15. N. Schaft, R.A. Willemsen, J. de Vries, B. Lankiewicz, B.W. Essers, J.W. Gratama, C.G. Figdor, R.L. Bolhuis, R. Debets, and G.J. Adema Peptide fine specificity of anti-glycoprotein 100 CTL is preserved following transfer of engineered TCR alpha beta genes into primary human T lymphocytes J. Immunol. 170 2003 2186 2194
16. M.P. Rubinstein, A.N. Kadima, M.L. Salem, C.L. Nguyen, W.E. Gillanders, M.I. Nishimura, and D.J. Cole Transfer of TCR genes into mature T cells is accompanied by the maintenance of parental T cell avidity J. Immunol. 170 2003 1209 1217
17. H.W. Kessels, M.C. Wolkers, d.B. van, M.A. van der Valk, and T.N. Schumacher Immunotherapy through TCR gene transfer Nat. Immunol. 2 2001 957 961
18. A. Calogero, G.A. Hospers, K.M. Kruse, P.I. Schrier, N.H. Mulder, E. Hooijberg, and L.F. de Leij Retargeting of a T cell line by anti MAGE-3/HLA-A2 alpha beta TCR gene transfer Anticancer Res. 20 2000 1793 1799
19. H. Yssel, J.E. De Vries, M. Koken, W. Van Blitterswijk, and H. Spits Serum-free medium for generation and propagation of functional human cytotoxic and helper T cell clones J. Immunol. Methods 72 1984 219 227
20. + T cell clones by ectopic expression of telomerase reverse transcriptase J. Immunol. 165 2000 4239 4245
21. S.P. Clark, B. Arden, D. Kabelitz, and T.W. Mak Comparison of human and mouse T-cell receptor variable gene segment subfamilies Immunogenetics 42 1995 531 540
22. B. Arden, S.P. Clark, D. Kabelitz, and T.W. Mak Human T-cell receptor variable gene segment families Immunogenetics 42 1995 455 500
23. T.M. Kinsella, and G.P. Nolan Episomal vectors rapidly and stably produce high-titer recombinant retrovirus Hum. Gene Ther. 7 1996 1405 1413
24. M.H. Heemskerk, E. Hooijberg, J.J. Ruizendaal, M.M. van der Weide, E. Kueter, A.Q. Bakker, T.N. Schumacher, and H. Spits Enrichment of an antigen-specific T cell response by retrovirally transduced human dendritic cells Cell. Immunol. 195 1999 10 17
25. C.A. Aarnoudse, M. Kruse, R. Konopitzky, N. Brouwenstijn, and P.I. Schrier TCR reconstitution in Jurkat reporter cells facilitates the identification of novel tumor antigens by cDNA expression cloning Int. J. Cancer 99 2002 7 13
26. E. Hooijberg, A.Q. Bakker, J.J. Ruizendaal, and H. Spits NFAT-controlled expression of GFP permits visualization and isolation of antigen-stimulated primary human T cells Blood 96 2000 459 466
27. S.R. Riddell, and P.D. Greenberg T cell therapy of human CMV and EBV infection in immunocompromised hosts Rev. Med. Virol. 7 1997 181 192
28. S.R. Riddell, K.S. Watanabe, J.M. Goodrich, C.R. Li, M.E. Agha, and P.D. Greenberg Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones Science 257 1992 238 241
29. P. Romero, J.C. Cerottini, and D.E. Speiser Monitoring tumor antigen specific T-cell responses in cancer patients and phase I clinical trials of peptide-based vaccination Cancer Immunol. Immunother. 53 2004 249 255
30. Z. Dembic, W. Haas, S. Weiss, J. McCubrey, H. Kiefer, H. von Boehmer, and M. Steinmetz Transfer of specificity by murine alpha and beta T-cell receptor genes Nature 320 1986 232 238
31. L.J. Cooper, M. Kalos, D.A. Lewinsohn, S.R. Riddell, and P.D. Greenberg Transfer of specificity for human immunodeficiency virus type 1 into primary human T lymphocytes by introduction of T-cell receptor genes J. Virol. 74 2000 8207 8212
32. D.B. Sant'Angelo, P. Cresswell, C.A. Janeway Jr., and L.K. Denzin Maintenance of TCR clonality in T cells expressing genes for two TCR heterodimers Proc. Natl. Acad. Sci. U. S. A. 98 2001 6824 6829
33. M.K. Slifka, and J.L. Whitton Functional avidity maturation of CD8(+) T cells without selection of higher affinity TCR Nat. Immunol. 2 2001 711 717
34. O.S. Kustikova, A. Wahlers, K. Kuhlcke, B. Stahle, A.R. Zander, C. Baum, and B. Fehse Dose finding with retroviral vectors: correlation of retroviral vector copy numbers in single cells with gene transfer efficiency in a cell population Blood 102 2003 3934 3937
35. R.E. Royal, M.H. Kershaw, M.E. Reeves, G. Wang, T. Daly, J. Treisman, J. Lam, and P. Hwu Increased functional expression of transgene in primary human lymphocytes using retroviral vectors modified with IRES and splicing motifs Gene Ther. 9 2002 1085 1092
36. E.M. Slimko, and H.A. Lester Codon optimization of Caenorhabditis elegans GluCl ion channel genes for mammalian cells dramatically improves expression levels J. Neurosci. Methods 124 2003 75 81
37. W.J. Liu, F. Gao, K.N. Zhao, W. Zhao, G.J. Fernando, R. Thomas, and I.H. Frazer Codon modified human papillomavirus type 16 E7 DNA vaccine enhances cytotoxic T-lymphocyte induction and anti-tumour activity Virology 301 2002 43 52
38. M.H. Kershaw, J.A. Westwood, and P. Hwu Dual-specific T cells combine proliferation and antitumor activity Nat. Biotechnol. 20 2002 1221 1227
39. M. Gladow, W. Uckert, and T. Blankenstein Dual T cell receptor T cells with two defined specificities mediate tumor suppression via both receptors Eur. J. Immunol. 34 2004 1882 1891
40. M.H. Heemskerk, M. Hoogeboom, R. Hagedoorn, M.G. Kester, R. Willemze, and J.H. Falkenburg Reprogramming of virus-specific T cells into leukemia-reactive T cells using T cell receptor gene transfer J. Exp. Med. 199 2004 885 894